James Archie Harrell Jr., Chief Commercial Officer at Avalo Therapeutics, Inc. (AVTX), bought 1,093 shares at $1.57 ($2K) on 2021-12-10, disclosed to the SEC on 2021-12-14.
Open-market purchase of $2k AVTX by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CERC | BUY | 2020-06-11 | $40K | — | Filing → |
| CERC | BUY | 2019-12-11 | $9K | — | Filing → |
| CERC | BUY | 2019-06-11 | $13K | — | Filing → |